ReviewCurrent oncology (Toronto, Ont.)2023
Single-Port Robot-Assisted Radical Prostatectomy: Where Do We Stand?
Review in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- da VinciBMC surgery · 2026Pooled it
- Outcomes of robot-assisted radical prostatectomy with novel robotic platforms vs da Vinci multiport systems: a systematic review and network meta-analysis.Prostate cancer and prostatic diseases · 2026Pooled it
- Perioperative efficiency and clinical outcomes of single-port versus multi-port robot-assisted radical prostatectomy: an updated meta-analysis.Journal of robotic surgery · 2025Pooled it
- Single port robot-assisted radical and simple prostatectomy: a systematic review and meta-analysis.Prostate cancer and prostatic diseases · 2025Pooled it
- Global research trends in single-port robot-assisted kidney surgery: a bibliometric and visualization analysis.Journal of robotic surgery · 2026Article
- The evolving landscape of robot-assisted radical prostatectomy: A comprehensive review of surgical techniques.Investigative and clinical urology · 2026Review
- Single-port robotic radical prostatectomy: early results from a UK centre.World journal of urology · 2026Article
- Single-port versus multi-port robotic radical prostatectomy: a within-surgeon, propensity-matched analysis of platform-related effects.Journal of robotic surgery · 2026Article
- Global research trends and thematic evolution of nerve-sparing and functional recovery after robot-assisted radical prostatectomy for prostate cancer: a bibliometric and visualisation analysis.Journal of robotic surgery · 2026Article
- Initial case series and perioperative outcomes of single-port robotic radical prostatectomy: the Italian experience.The Canadian journal of urology · 2026Article
- Surgical Treatment for Localized Prostate Cancer: A Narrative Review of Literature.Journal of clinical medicine · 2025Review
- The Current Role of Single-Site Robotic Approach in Liver Resection: A Systematic Review.Life (Basel, Switzerland) · 2024Review
- Robotic surgery in urology: Recent advances.Asian journal of urology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2018, the da Vinci Single Port (SP) robotic system was approved by the US Food and Drug Administration for urologic procedures. Available studies for the application of SP to prostate cancer surgery are limited. The aim of our study is to summarize the current evidence on the techniques and outcomes of SP robot-assisted radical prostatectomy (SP-RARLP) procedures. A narrative review of the literature was performed in January 2023. Preliminary results suggest that SP-RALP is safe and feasible, and it can offer comparable outcomes to the standard multiport RALP. Extraperitoneal and transvesical SP-RALP appear to be the two most promising approaches, as they offer decreased invasiveness, potentially shorter length of stay, and better pain control. Long-term, high-quality data are missing and further validation with prospective studies across different sites is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.